Anti-WT1 monoclonal antibody (DCABH-811)

Mouse anti-Human WT1 monoclonal antibody for ELISA, WB, IHC-P Datasheet

Online Inquiry Add to basket   

Specifications


Host Species
Mouse
Antibody Isotype
IgG2a
Clone
2F0
Species Reactivity
Human
Immunogen
Recombinant full length Human Wilms Tumor Protein.
Conjugate
Unconjugated

Applications


Application Notes
IHC-P: 10 μg/ml.
*Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.

Target


Alternative Names
WT1; Wilms tumor 1; GUD; Wilms tumor protein; AWT1; WAGR
Entrez Gene ID
UniProt ID

Product Background


Gene summary
WT1 (Wilms Tumor 1) is a Protein Coding gene. Diseases associated with WT1 include denys-drash syndrome and wilms tumor susceptibility-5. Among its related pathways are Integrated Pancreatic Cancer Pathway and Regulation of Telomerase. GO annotations related to this gene include nucleic acid binding and sequence-specific DNA binding. An important paralog of this gene is EGR1. This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated.
Pathway
Regulation of Telomerase, organism-specific biosystem; Transcriptional misregulation in cancer, organism-specific biosystem; Transcriptional misregulation in cancer, conserved biosystem.

Citations


Have you cited DCABH-811 in a publication? Let us know and earn a reward for your research.

References


Miyauchi, M; Toyoda, M; et al. Hypertrophy and Loss of Podocytes in Diabetic Nephropathy. INTERNAL MEDICINE 48:1615-1620(2009).
McCluggage, WG; Oliva, E; et al. An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 23:330-336(2004).

Custom Antibody Labeling


We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More

Customer Reviews


Write a review, share your experiences with others and get rewarded !

Online Inquiry

Name
Phone *
E-mail Address *
Service & Products Interested *
Project Description
Verification Code * Please input "diagnostics" as verification code.

Online Inquiry

Order Info: Anti-WT1 monoclonal antibody

Online Inquiry
  Interested in larger quantities ? request a quote!
  Protocol may be improved. Please feel free to contact us to obtain the latest version.!
  15% off your first purchase

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

OUR PROMISE TO YOU Guaranteed product quality expert customer support

Inquiry Basket